Physician profile
Tej Bansal
NPI 1760419675
$4,093.94
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,422 · 2020: $1,048 · 2021: $1,207 · 2022: $204 · 2023: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $830.91 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $769.24 | 2019-2021 | |
| Amarin Pharma, INC. | $400.47 | 2019-2021 | |
| Amgen INC. | $327.86 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $317.04 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $306.10 | 2019-2021 | |
| Lilly USA, LLC | $241.35 | 2019-2022 | |
| Corcept Therapeutics | $241.26 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $112.77 | 2020-2021 | |
| Lifescan, INC. | $96.03 | 2020-2021 | |
| Abbvie INC. | $71.08 | 2020-2021 | |
| Shire North American Group INC | $66.41 | 2019 | |
| Merck Sharp & Dohme LLC | $53.84 | 2019 | |
| Novo Nordisk INC | $41.97 | 2020 | |
| Mannkind Corporation | $41.67 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $27.53 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $25.95 | 2019 | |
| Janssen Pharmaceuticals, INC | $25.36 | 2020 | |
| Medtronic Minimed, INC. | $22.66 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $18.71 | 2021 | |
| Abbott Laboratories | $15.62 | 2019 | |
| Dexcom, INC. | $14.19 | 2021 | |
| Valeritas, INC. | $13.43 | 2019 | |
| Radius Health, INC. | $12.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tej Bansal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.